Mr. Anand has earned the AIPPI Award of Merit and INTA’s President’s Award, and has been recognised by the Financial Times as one of the 20 most innovative practitioners of the past two decades. He has appeared in over 5,000 cases during 46 years of practice as an intellectual property (IP) lawyer.
To his credit are patent lawsuits that transformed India’s pharmaceutical and biotechnology enforcement regime, including Merck v Glenmark, Roche v Cipla, and the Monsanto case.
Mr. Anand has also broken new ground in Indian IP jurisprudence with the country’s first anti-anti-suit injunction (InterDigital v Xiaomi); a landmark judgment on a product-by-process patent (Vifor v MSN Laboratories); India’s first pro tem security order, in favour of Nokia; the Nokia–Lenovo multi-year, multi-technology agreement; a software patent lawsuit conferring protection (the Ferid Allani case); the development of a damages culture in cases recognising punitive as well as compensatory, exemplary, and aggravated damages (Philips v AmazeStore); and India’s first post-trial standard-essential patent judgment (Philips v Bhagirathi).
